About Alfa Cytology
Alfa Cytology, a research solutions provider, focused on cancer therapeutic development and preclinical studies. From the complex phases of target discovery to IND application, we offer a seamless experience. Alfa Cytology specializes in providing comprehensive and efficient preclinical research services to meet the diverse needs of drug development. Our services include drug efficacy studies, pharmacokinetic studies, drug safety evaluations, etc.
FAQs
- When was Alfa Cytology founded?
- Alfa Cytology was founded in 2024.
- Who is the CEO of Alfa Cytology?
- Toya Davis is the CEO.
- What industries or markets does Alfa Cytology operate in?
- Alfa Cytology operates in the following markets: Contract Research Organization (CRO), Preclinical Research Services, Oncology Drug Development, Biotechnology, Pharmaceutical R&D Services, Target Discovery & Validation, IND Enabling Studies, Pharmacokinetics & ADME, Toxicology & Drug Safety Evaluation, and In Vivo & In Vitro Efficacy Studies.
- How many employees does Alfa Cytology have?
- Alfa Cytology has 51-200 employees.
- Does Alfa Cytology support remote work or working from home?
- Yes, Alfa Cytology is a remote-friendly company.
- Does Alfa Cytology offer a four-day work week?
- No, Alfa Cytology does not offer a four-day work week.
- What is Alfa Cytology's website?
- Alfa Cytology's website is alfacytology.com.
